305 results on '"Khac E"'
Search Results
2. Combined treatment of refractory ascites with an alfapump® plus hernia repair in the same surgical session: A retrospective, multicentre, European pilot study in cirrhotic patients
3. Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
4. Management of colon cancer in patients with cirrhosis: A review
5. Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based Study
6. Impact of Extra-Intestinal Manifestations at Diagnosis on Disease Outcome in Pediatric- and Elderly-Onset Crohn′s Disease: A French Population-Based Study
7. Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study
8. Grossesse et hépatite B en Picardie : traçabililité du dépistage et prévalence
9. Supplement to: Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.
10. Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases
11. Complete endoscopic healing is associated with lower disability than partial mucosal healing in Crohn's disease: a prospective multicentric study
12. P175 Complete endoscopic healing is associated with lower disability than partial mucosal healing in Crohn’s disease: a prospective multicentric study
13. Résultats et place du Fibroscan ® dans le diagnostic non invasif de la fibrose hépatique
14. S07.5LIVER STIFFNESS AND SERUM MARKER: COMPETITION OR SUPPLEMENTATION?
15. Randomised clinical trial: enteral nutrition does not improve the long-term outcome of alcoholic cirrhotic patients with jaundice
16. The non-invasive diagnosis of cirrhosis using the Fibroscan must be performed with cause-specific stiffness cut-offs
17. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests
18. Reagent strips and spontaneous bacterial peritonitis
19. Review article: the utility of reagent strips in the diagnosis of infected ascites in cirrhotic patients
20. Coeliac disease in chronic hepatitis C: a French multicentre prospective study
21. Un cancer du sigmoïde et un carcinome hépatocellulaire chez un patient cirrhotique
22. Efficacité et tolérance du traitement des sténoses biliaires malignes par technique du rendez-vous percutanée après échec de CPRE
23. P692 Positive histological margins is a risk factor of recurrence after ileocaecal resection in Crohn’s disease
24. Hépatite alcoolique aiguë sévère
25. Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial
26. Evolution and impact of obesity in patients on the liver transplant waiting list
27. Circulating micro-ARNs as biomarkers of alcohol liver disease and hepatocellular carcinoma
28. Efficacy and safety of 8 weeks of elbasvir/grazoprevir in HCV GT4-infected treatment-naīve participants
29. Changes in serum bile acid levels associated with bezafibrate add-on therapy in patients with primary biliary cholangitis and inadequate biochemical response to ursodeoxycholic acid: results from the BEZURSO trial (NCT01654731)
30. L’hépatite E : une infection émergente à ne pas méconnaître, notamment chez l’immunodéprimé. Étude transversale monocentrique
31. Prise en charge endoscopique des fistules gastriques après sleeve gastrectomy par prothèses double queue de cochon: Technique BARTOLI
32. A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)
33. Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
34. SAT-093 - Circulating micro-ARNs as biomarkers of alcohol liver disease and hepatocellular carcinoma
35. FRI-034 - Evolution and impact of obesity in patients on the liver transplant waiting list
36. PS-001 - Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial
37. GS-006 - Efficacy and safety of 8 weeks of elbasvir/grazoprevir in HCV GT4-infected treatment-naīve participants
38. LP05 : Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV genotype 3 infection: Interim analysis of a french multicenter compassionate use program
39. G08 : Incidence of hepatocellular carcinoma (HCC) and complications in alcoholic compensated cirrhosis. Preliminary results of a multicenter prospective French and belgian cohort (INCA Cirral)
40. P1288 : Budd chiari syndrome (BCS) in France from a large national cohort
41. Le syndrome hépato-pulmonaire
42. Le syndrome hepatopulmonaire
43. [Hepatopulmonary syndrome]
44. LBO-01 - A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)
45. O83 NON-INVASIVE DIAGNOSIS OF LIVER FIBROSIS BY FIBROSCAN IN PATIENTS WITH ALCOHOLIC LIVER DISEASE: A META-ANALYSIS WITH INDIVIDUAL DATA
46. O69 ALBUMIN INFUSION FOR BACTERIAL INFECTIONS OTHER THAN SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOTIC PATIENTS: A MULTICENTER RANDOMIZED CONTROLLED STUDY (ALB-CIRINF STUDY)
47. P089 Decrease of peripheral leucocytes BIM protein expression in Crohn's disease
48. Antibiotic prophylaxis for bacterial infections in cirrhotic patients with ascites
49. SAT-282 - Daclatasvir plus Sofosbuvir with or without Ribavirin in Patients with HCV Infection and Decompensated Cirrhosis: Interim Analysis of a French Multicentre Compassionate use Programme
50. ALCOHOL LIVER DISEASE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.